Literature DB >> 19661699

Improved isolation methods for mucosal leukocytes from small and large intestines in rats.

Jae-Sung Lee1, Kohsuke Oka, Mie Obara, Megumi Nishimukai, Yung-Choon Yoo, Kaori Yamada, Takamitsu Tsukahara, Keizo Nakayama, Hiroshi Hara, Satoshi Ishizuka.   

Abstract

We optimized the isolation protocol for intraepithelial lymphocytes (IELs) and lamina propria lymphocytes (LPLs) from the rat small intestine, and LPLs from even the rat large intestine. The major population of IELs in the small intestine was considered to be from the villus epithelia. The cytotoxicity of mucosal leukocytes was comparable among isolated fractions from both the small and large intestines, regardless of the population differences. Further analyses of the cells collected from other lymphoid tissues demonstrated that CD161(+) cells selectively accumulated in the intestinal lamina propria and did not recirculate through the lymph ducts. Our modified isolation protocol enables the collection of mucosal immune cells from the rat intestines without any deterioration of cell function and could contribute to a better understanding of dietary influences on the mucosal immune system.

Entities:  

Mesh:

Year:  2009        PMID: 19661699     DOI: 10.1271/bbb.90035

Source DB:  PubMed          Journal:  Biosci Biotechnol Biochem        ISSN: 0916-8451            Impact factor:   2.043


  4 in total

1.  Physiological concentrations of trans-11 18:1 vaccenic acid suppress pro-inflammatory markers under acute inflammation in isolated ICR mice splenocytes.

Authors:  Jae-Sung Lee; Ji-Na Lim; Tao Wang; Sang-Bum Lee; Jin-Hee Hwang; U-Suk Jung; Min-Jeong Kim; Seong-Ho Choi; Satoshi Ishizuka; Hong-Gu Lee
Journal:  Food Sci Biotechnol       Date:  2016-02-29       Impact factor: 2.391

2.  Gastrointestinal toxicities of 5-fluorouracil increase the proportion of regulatory T cells in intestinal tract: advantages of alternate-day S-1 administration.

Authors:  Taiki Kajiwara; Koh Miura; Shinobu Ohnuma; Miki Shimada; Toshihiro Komura; Masahide Toshima; Atsushi Kohyama; Katsuyoshi Kudoh; Sho Haneda; Hiroaki Musha; Takeshi Naitoh; Tetsuhiko Shirasaka; Michiaki Unno
Journal:  Int J Clin Oncol       Date:  2015-02-05       Impact factor: 3.402

3.  Preconditioning with intravenous colitic cell-free DNA prevents DSS-colitis by altering TLR9-associated gene expression profile.

Authors:  Györgyi Műzes; Ferenc Sipos; István Fűri; Miklós Constantinovits; Sándor Spisák; Barnabás Wichmann; Gábor Valcz; Zsolt Tulassay; Béla Molnár
Journal:  Dig Dis Sci       Date:  2014-09-13       Impact factor: 3.199

4.  Intravenous administration of a single-dose free-circulating DNA of colitic origin improves severe murine DSS-colitis.

Authors:  Ferenc Sipos; Györgyi Műzes; István Fűri; Sándor Spisák; Barnabás Wichmann; Tiana M Germann; Miklós Constantinovits; Tibor Krenács; Zsolt Tulassay; Béla Molnár
Journal:  Pathol Oncol Res       Date:  2014-04-11       Impact factor: 3.201

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.